Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

Overview of attention for article published in Journal of General Internal Medicine, March 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,953 followers.

RT @JournalGIM: Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the… https:…

RT @JournalGIM: Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the… https:…

Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the… https://t.co/hAjKxi6id5

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.